Histone demethylase KDM5B as a therapeutic target for cancer therapy

Medicine and Dentistry

• 3-Deazaneplanocin A 50%
• Abacavir 50%
• Antivirus Agent 100%
• Breast Cancer 50%
• Cancer 50%
• Cancer Research 50%
• Cancer Therapy 100%
• Cancer Treatment 50%
• Decitabine 50%
• Docking (Molecular) 50%
• Entecavir 50%
• Enzyme Active Site 50%
• Enzymes 50%
• Histone Demethylase 100%
• Lead 50%
• Liver Cancer 50%
• Lung Cancer 50%
• Lysine 50%
• Penciclovir 50%
• Prostate Cancer 50%
• Skin Cancer 50%
• Therapeutics 100%
• Toxicity 50%

Pharmacology, Toxicology and Pharmaceutical Science

• 3-Deazaneplanocin A 33%
• Abacavir 33%
• Antivirus Agent 66%
• Breast Cancer 33%
• Decitabine 33%
• Entecavir 33%
• Enzymes 33%
• Histone Demethylase 100%
• Lead 33%
• Liver Cancer 33%
• Lung Cancer 33%
• Lysine 33%
• Malignant Neoplasm 100%
• Penciclovir 33%
• Prostate Cancer 33%
• Repurposing 33%
• Skin Cancer 33%
• Toxicity 33%